Boehringer Ingelheim: basic facts
General Information
Boehringer Ingelheim's Home Page
Financial
1st Half Results, 2000
Year End Financial Summary, 1999
Sales by geographic region, 1999.
Drugs Related to IPR Disputes
Nevirapine
December 19, 2000.
Letter from (Indian generics manufacturer) Cipla to Boehringer-Ingelheim
requesting a voluntary, nonexclusive license to make and distribute Nevirapine.
November 28, 2000.
UNAIDS Welcomes Boehringer Ingelheim's Commitment to Offer Nevirapine Free of Charge to Developing Countries For Preventionof Mother-to-Child Transmission of HIV.
November 28, 2000.
World AIDS Day Report:First Supplie in the VIRAMUNE Donation Program for Developing Countries.
August 4, 2000.
Price difference between generic Nevirapine in India and Nevirapine sold by Boehringer-Ingelheim.
July 8, 2000.
The Activist Response to Boehringer Ingelheim's Drug Donation.
Philanthropy
Boehringer Ingelheim donated $1 million to the
Elizabeth Glaser Pediatric AIDS Foundation.
Contact information.
900 Ridgebury Road
PO Box 368
Ridgefield, CT 06877
203-798-9988
CPT Home
CPT Intellectual Property and Healthcare page
CPT Companies page